Insider: McNeill Jonathan Chief Business Officer - Dyne Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 132,411 | 0 | 132,411 |
| Value | $1,665,730.38 | $0.00 | $1,665,730.38 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/19/2024 | DDS | 2,400 | Direct | COM | $45.01 | $108,024.00 | 132,411 |
| 08/19/2024 | DDS | 305 | Direct | COM | $46.00 | $14,030.00 | 132,106 |
| 06/11/2024 | DDS | 1,823 | Direct | COM | $31.34 | $57,132.82 | 134,811 |
| 05/16/2024 | DDS | 2,279 | Direct | COM | $28.20 | $64,267.80 | 137,129 |
| 05/16/2024 | DDS | 495 | Direct | COM | $28.59 | $14,152.05 | 136,634 |
| 03/11/2024 | DDS | 17,825 | Direct | COM | $25.48 | $454,181.00 | 141,184 |
| 03/11/2024 | DDS | 1,776 | Direct | COM | $25.71 | $45,660.96 | 139,408 |
| 03/08/2024 | DDS | 54,648 | Direct | COM | $26.72 | $1,460,194.56 | 141,873 |
| 03/08/2024 | DDS | 34,663 | Direct | COM | $25.46 | $882,519.98 | 196,521 |
| 03/08/2024 | DDS | 689 | Direct | COM | $27.31 | $18,816.59 | 141,184 |
| 03/07/2024 | DDS | 2,434 | Direct | COM | $25.85 | $62,918.90 | 141,184 |
| 03/01/2024 | DDS | 14,103 | Direct | COM | $28.25 | $398,409.75 | 153,775 |
| 03/01/2024 | DDS | 1,442 | Direct | COM | $29.70 | $42,827.40 | 143,618 |
| 03/01/2024 | DDS | 8,715 | Direct | COM | $29.06 | $253,257.90 | 145,060 |
| 02/29/2024 | DDS | 4,268 | Direct | COM | $27.50 | $117,370.00 | 143,618 |
| 01/26/2024 | DDS | 178 | Direct | COM | $25.14 | $4,474.92 | 143,618 |
| 01/26/2024 | DDS | 19,822 | Direct | COM | $24.52 | $486,035.44 | 143,796 |
| 12/11/2023 | DDS | 1,245 | Direct | COM | $10.72 | $13,346.40 | 155,518 |
| 09/18/2023 | DDS | 1,261 | Direct | COM | $9.41 | $11,866.01 | 60,605 |
| 09/12/2023 | DDS | 1,266 | Direct | COM | $10.41 | $13,179.06 | 61,866 |
| 06/13/2023 | DDS | 1,259 | Direct | COM | $12.43 | $15,649.37 | 63,132 |
| 06/12/2023 | DDS | 1,000 | Direct | COM | $13.00 | $13,000.00 | 64,391 |
| 03/14/2023 | DDS | 1,209 | Direct | COM | $13.33 | $16,115.97 | 65,391 |
| 03/13/2023 | DDS | 1,000 | Direct | COM | $13.00 | $13,000.00 | 66,600 |
| 01/18/2023 | DDS | 10,000 | Direct | COM | $14.03 | $140,300.00 | 67,600 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research